Nightingale Health Plc's Annual General Meeting (AGM) was held on Thursday, 28 October 2021, at 4:00 p.m. (EEST) at Sanomatalo, Töölönlahdenkatu 2, FI-00100 Helsinki.
The Board of Directors of the Company had resolved on an exceptional meeting procedure pursuant to the Act on a temporary derogation from the Finnish Companies Act (375/2021, the “Temporary Act”). In order to limit the spread of the COVID-19 pandemic, the Company had resolved to take actions enabled by the temporary legislation in order to hold the General Meeting in a predictable manner, taking account the health and safety of the shareholders, the Company’s personnel and other stakeholders.
Registration to the Annual General Meeting and voting takes place here: https://ir1.innovatics.fi/ir/en/nightingale/Agm/Registration/2021_1/Accept
The company did not receive any counterproposals by the deadline.
Proxy form and voting instructions for a representative chosen by the shareholder: Proxy form and voting instructions
Proxy form and voting instructions for the representative service provided by the company: Proxy form and voting instructions - Borenius Attorneys
The Board of Directors proposes to the General Meeting that until the end of the next Annual General Meeting, the current members of the Board of Directors Tom Jansson, Antti Kangas, Olli Karhi, Lotta Kopra, Leena Niemistö, Timo Soininen and Teemu Suna shall be re-elected.
The above-mentioned nominated persons have given their consent to the election. The presentations of the persons nominated for the Board of Directors are available at https://nightingalehealth.com/investors/board-of-directors.
A shareholder has the right to have a matter falling within the competence of the general meeting under the Finnish Limited Liability Companies Act (624/2006, as amended; the "Companies Act") included on the agenda of the general meeting. A request from a shareholder to have a matter included on the agenda of the Annual General Meeting 2021 shall be sent to the company’s Board of Directors in writing no later than on 8 September 2021. Such request together with a proposal for a resolution shall be sent by email to agm[at]nightingalehealth.com or by mail to the following address: Nightingale Health Plc, Chief Legal Officer Minja Salmio, Mannerheimintie 164a 00300 Helsinki, Finland.
If the Board of Directors convenes the Annual General Meeting in accordance with the Act concerning temporary deviation from the Finnish Limited Liability Companies Act (375/2021, the “Temporary Act”) a shareholder’s right to have a matter included on the agenda of the Annual General Meeting and its conditions are laid down in the Companies Act and in the Temporary Act.
No requests were made by the deadline.